Amphetamine/Dextroamphetamine vs Modafinil
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.
Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.
Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.
See our Terms of Use and Editorial Policy.
Adderall (amphetamine/dextroamphetamine) and modafinil (Provigil) are both used to improve focus and wakefulness, but they are fundamentally different medications with distinct mechanisms, indications, and risk profiles [1][2].
Adderall is a Schedule II stimulant approved for ADHD and narcolepsy that directly increases dopamine and norepinephrine levels [1]. Modafinil is a Schedule IV wakefulness-promoting agent approved for narcolepsy, shift work sleep disorder, and obstructive sleep apnea-related sleepiness [2].
Modafinil's lower abuse potential (Schedule IV vs. II) and milder side effect profile make it an important alternative, though it is generally considered less effective for ADHD and is not FDA-approved for that indication [2][3].
Amphetamine/Dextroamphetamine vs Modafinil: Side-by-side comparison
| Category | Amphetamine/Dextroamphetamine | Modafinil |
|---|---|---|
| Drug Class | Amphetamine stimulant | Wakefulness-promoting agent |
| Generic Name | Amphetamine/dextroamphetamine | Modafinil |
| Brand Name | Adderall, Adderall XR | Provigil |
| FDA Approved For | ADHD, narcolepsy | Narcolepsy, shift work disorder, OSA sleepiness |
| How It Works | Increases dopamine and norepinephrine release | Dopamine reuptake inhibition + histamine/orexin pathways |
| DEA Schedule | Schedule II (high abuse potential) | Schedule IV (low abuse potential) |
| Typical Dose | 10-30 mg/day | 200 mg once daily |
| Common Side Effects | Decreased appetite, insomnia, dry mouth, tachycardia | Headache, nausea, nervousness, insomnia |
| Appetite Suppression | Significant | Mild |
| Dependence Risk | High | Low |
| ADHD Efficacy | High (first-line, FDA-approved) | Modest (not FDA-approved for ADHD) |
| Cost (Generic) | $20-$60/month | $20-$60/month |
Efficacy: How well does each drug work?
For ADHD, Adderall is substantially more effective, with robust clinical trial data and FDA approval [1]. Effect sizes for amphetamines in ADHD are 0.8-1.3 [4]. Modafinil has been studied for ADHD (showing modest benefit in some trials) but was denied FDA approval for this indication due to a rare case of Stevens-Johnson syndrome in pediatric trials [2][3].
For narcolepsy, both are effective. Modafinil is typically first-line due to its lower abuse potential and better tolerability [2]. Adderall (or other amphetamines) may be needed for narcolepsy with cataplexy or when modafinil provides insufficient wakefulness [1].
For shift work sleep disorder, modafinil has the FDA indication and established evidence [2]. Adderall is not approved for this use.
Modafinil's mechanism is incompletely understood but appears to involve dopamine reuptake inhibition, histamine, and orexin pathways [2]. Its effect on wakefulness is often described as more subtle and natural-feeling compared to amphetamine stimulation.
Side effects comparison
Adderall has a stronger side effect profile typical of amphetamines: decreased appetite (significant), insomnia, dry mouth, anxiety, tachycardia, elevated blood pressure, and risk of dependence [1]. Cardiovascular and psychiatric monitoring is recommended.
Modafinil is generally better tolerated: headache (34%), nausea (11%), nervousness (7%), and insomnia (5%) are the most common effects [2]. Appetite suppression is much milder than with Adderall. Cardiovascular effects are less pronounced.
Modafinil carries a rare risk of serious skin reactions (SJS/TEN), which led to the rejection of its pediatric ADHD indication [2]. It also reduces the effectiveness of hormonal contraceptives — women must use alternative or additional birth control [2].
Adderall has significantly higher abuse and dependence potential (Schedule II vs. IV). Physical dependence develops with chronic use. Modafinil has low abuse potential and is not associated with significant withdrawal [1][2].
Cost comparison
Convenience and dosing
Both are oral medications. Adderall IR requires 2-3 daily doses; Adderall XR is once daily [1]. Modafinil is taken once daily, typically in the morning (or before a shift for shift workers) [2]. Modafinil does not require titration — most patients start at the effective dose (200 mg). Adderall requires dose titration to find the optimal amount.
Which is right for you?
Adderall is the clear choice for ADHD — it has FDA approval, robust efficacy data, and is first-line treatment [1]. It is also preferred for narcolepsy with cataplexy or when strong stimulant effect is needed.
Modafinil is preferred for narcolepsy as first-line therapy, shift work sleep disorder, and situations where abuse potential must be minimized [2]. Some clinicians use it off-label for ADHD when stimulants are contraindicated or not tolerated.
These medications should not be viewed as interchangeable — they serve different clinical needs [1][2][3].
This information is for educational purposes only. Consult your healthcare provider.
Frequently asked questions
References
- [Regulatory] Adderall XR (mixed amphetamine salts) prescribing information. Teva. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021303s039lbl.pdf Accessed 2025-06-15.
- [Regulatory] Modafinil (Provigil) prescribing information. Teva. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020717s043lbl.pdf Accessed 2025-06-15.
- [Regulatory] Turner D. A review of the use of modafinil for ADHD. Expert Rev Neurother. 2006;6(4):455-468. https://doi.org/10.1586/14737175.6.4.455 Accessed 2025-06-15.
- [Regulatory] Cortese S, et al. Comparative efficacy and tolerability of medications for ADHD. Lancet Psychiatry. 2018;5(9):727-738. https://doi.org/10.1016/S2215-0366(18)30269-4 Accessed 2025-06-15.
- [Observational] GoodRx price comparison: Adderall and modafinil. https://www.goodrx.com Accessed 2025-06-15.
Written and fact-checked by PrescriptionDrugs.org Editorial Team
Last updated: